Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA, USA.
J Inherit Metab Dis. 2013 Nov;36(6):1049-61. doi: 10.1007/s10545-012-9575-x. Epub 2013 Jan 15.
Classic galactosemia is a potentially lethal disorder that results from profound deficiency of galactose-1-phosphate uridylyltransferase (GALT), the second enzyme in the Leloir pathway of galactose metabolism. Although early diagnosis and rigorous dietary restriction of galactose prevent or resolve the potentially lethal acute symptoms, patients are at markedly increased risk of long-term complications including significant cognitive, speech, and behavioral difficulties, among other problems. The mechanisms that underlie these long-term complications remain unclear, as do the factors that modify their severity. Here we explored the scholastic and behavioral outcomes experienced by a cohort of 54 school age children with classic galactosemia. Data collected included survey responses from parents and teachers, school records including standardized test scores, and GALT genotype data used to estimate predicted residual GALT activity based on a yeast expression system. As expected, many but not all of the children in our study demonstrated speech, scholastic, and behavioral difficulties. Perhaps most striking, we found that predicted cryptic residual GALT activity, often below the threshold of detection of clinical assays, appeared to modify scholastic outcome. These data raise the intriguing possibility that cryptic GALT activity might also influence the severity of other long-term complications in classic galactosemia.
经典型半乳糖血症是一种潜在致命的疾病,由半乳糖-1-磷酸尿苷酰转移酶(GALT)的严重缺乏引起,GALT 是半乳糖代谢 Leloir 途径中的第二种酶。尽管早期诊断和严格限制半乳糖饮食可以预防或解决潜在致命的急性症状,但患者存在明显的长期并发症风险,包括认知、言语和行为等方面的严重困难。这些长期并发症的发生机制尚不清楚,影响其严重程度的因素也不清楚。在这里,我们研究了经典半乳糖血症的 54 名学龄儿童队列的学业和行为结果。收集的数据包括来自家长和教师的调查回复、包括标准化考试成绩在内的学校记录,以及 GALT 基因型数据,用于根据酵母表达系统估计预测的隐性 GALT 活性。正如预期的那样,我们研究中的许多但不是所有儿童都表现出言语、学业和行为困难。最引人注目的是,我们发现预测的隐匿性残余 GALT 活性(通常低于临床检测阈值)似乎会影响学业成绩。这些数据提出了一个有趣的可能性,即隐匿性 GALT 活性也可能影响经典半乳糖血症其他长期并发症的严重程度。